Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(21 Publications)
Rabbit Recombinant Monoclonal EIF2S1 phospho S51 antibody. Carrier free. Suitable for Dot, IHC-P, WB and reacts with Synthetic peptide - Human, Human, Mouse, Rat, Neurospora crassa samples. Cited in 21 publications.
View Alternative Names
EIF2A, EIF2S1, Eukaryotic translation initiation factor 2 subunit 1, Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha, eIF2-alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
This IHC data was generated using the same anti-phospho EIF2S1 Serine 51 antibody clone, E90, in a different buffer formulation (cat# ab32157).
Immunohistochemical analysis of paraffin-embedded human liver carcinoma using ab32157 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
ab32157 showing positive staining in Hepatocellular carcinoma tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
Immunohistochemical analysis of paraffin-embedded human lung cancer sections labeling EIF2S1 with ab32157 at 1/4000 dilution (0.37 μg/mL). Hematoxylin was used as counterstain. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Antigen retrieval was heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes.
Positive staining on human lung cancer without alkaline phosphatase treatment (image A). No staining on human lung cancer with alkaline phosphatase treatment (image B)
The section was incubated with ab32157 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
Immunohistochemical analysis of paraffin-embedded mouse pancreatic cancer sections labeling EIF2S1 with ab32157 at 1/4000 dilution (0.37 μg/mL). Hematoxylin was used as counterstain. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Antigen retrieval was heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes.
Positive staining on mouse pancreatic cancer without alkaline phosphatase treatment (image A). No staining on mouse pancreatic cancer with alkaline phosphatase treatment (image B)
The section was incubated with ab32157 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
- WB
Lab
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Blocking buffer and concentration : 2% BSA/TBST.
Diluting buffer and concentration : 2% BSA /TBST.
Exposure time : 10 seconds
All lanes:
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] (<a href='/en-us/products/primary-antibodies/eif2s1-phospho-s51-antibody-e90-ab32157'>ab32157</a>) at 1/20000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysates at 20 µg
Lane 2:
HeLa treated with Calyculin A whole cell lysates at 20 µg
Lane 3:
HeLa treated with Calyculin A and phosphatase whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 36 kDa
Observed band size: 36 kDa
false
- WB
Unknown
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
All lanes:
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] (<a href='/en-us/products/primary-antibodies/eif2s1-phospho-s51-antibody-e90-ab32157'>ab32157</a>) at 1/500 dilution
All lanes:
PC12 cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab6721'>ab6721</a>)
Predicted band size: 36 kDa
Observed band size: 36 kDa
false
- WB
Lab
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
Blocking/Diluting buffer and concentration 5% NFDM/TBST
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
All lanes:
Western blot - Anti-EIF2S1 (phospho S51) antibody [E90] (<a href='/en-us/products/primary-antibodies/eif2s1-phospho-s51-antibody-e90-ab32157'>ab32157</a>) at 1/1000 dilution
Lane 1:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) Whole cell lysates at 15 µg
Lane 2:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 5 ug/ml tunicamycin for 18 hours whole cell lysates at 15 µg
Lane 3:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 5 ug/ml tunicamycin for 18 hours whole cell lysates. Then the membrane was incubated with alkaline phosphatase. at 15 µg
Lane 4:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 5 ug/ml tunicamycin for 18 hours whole cell lysates. Then the membrane was incubated with lambda phosphatase. at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 36 kDa
Observed band size: 36 kDa
false
Exposure time: 180s
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
ab32157 showing positive staining in Colonic adenocarcinoma tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
ab32157 showing positive staining in Cervical carcinoma tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
ab32157 showing positive staining in Breast carcinoma tissue.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Dot
Unknown
Dot Blot - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
Dot blot analysis on antigen peptide. A nitrocellulose membrane was spotted with (1) phospho-peptide and (2) non-phospho-peptide at 5, 1, and 0.1 ng, and then blotted with ab32157 at 1 : 500 dilution. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
- Dot
Lab
Dot Blot - Anti-EIF2S1 (phospho S51) antibody [E90] - BSA and Azide free (AB214434)
Dot blot analysis of EIF2S1 (pS51) phospho peptide (Lane 1), EIF2S1 non-phospho peptide (Lane 2) with ab32157 at a dilution of 1/1000. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at a dilution of 1/100000.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32157).
Related conjugates and formulations (1)
-
Anti-EIF2S1 (phospho S51) antibody [E90]
Reactivity data
Product details
ab214434 is the carrier-free version of ab32157.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF2α acts as a regulatory component of the eIF2 complex which is central to initiating translation in eukaryotic cells. Phosphorylation of eIF2α leads to inhibition of the exchange of GDP to GTP on eIF2 effectively reducing global protein synthesis while allowing the translation of specific mRNAs involved in stress responses. The eIF2α forms part of the eIF2 complex working closely with other subunits to exert its regulatory functions.
Pathways
EIF2α is involved in the integrated stress response (ISR) and other protein synthesis pathways. The phosphorylation state of eIF2α is important in ISR linking it to proteins such as PERK and GCN2 which respond to various stress signals. Phospho-eIF2α plays a significant role in modulating the translation response to cellular stress ensuring cells can adapt or initiate apoptosis depending on the conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Molecular carcinogenesis 63:1783-1799 PubMed38896079
2024
Applications
Unspecified application
Species
Unspecified reactive species
Microbiology spectrum 10:e0150922 PubMed36326498
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 11: PubMed35507395
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 17:7017-7026 PubMed29568863
2018
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 8:ra27 PubMed25759478
2015
Applications
WB
Species
Human
PloS one 9:e101643 PubMed24992504
2014
Applications
WB
Species
Mouse
PloS one 9:e88863 PubMed24533157
2014
Applications
WB
Species
Unspecified reactive species
Scientific reports 3:3219 PubMed24225777
2013
Applications
WB
Species
Human
Nucleic acids research 41:7683-99 PubMed23804767
2013
Applications
WB
Species
Mouse
Physiological genomics 45:477-86 PubMed23572537
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com